// App-Quantinova.ai

PO0589 : The Impact of Decline in Renal Function on the Clinical and Economic Burden of CKD: An Application of the DAPA-CKD Cost-Effectiveness Model

Researchers

Presenter

  • McEwan Philip

Principal Investigators

  • Garcia Sanchez Juan Jose

  • Bergenheim Klas

  • Darlington OliverT

  • Wheeler DavidC

  • L Heerspink HiddoJan

Medical Centers

  • (HEOR) Ltd, Health Economics and Outcomes Research, Cardiff, United Kingdom

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

  • Kings College London, London, United Kingdom

  • University of Groningen, Groningen, Netherlands

Locations

  • United Kingdom

  • Sweden

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

Disease

  • Microvascular complications of diabetes 1

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved